These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas. Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533 [TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. Elder EE; Elder G; Larsson C J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371 [TBL] [Abstract][Full Text] [Related]
6. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma. Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Solórzano CC; Kim LT Ann Surg Oncol; 2020 May; 27(5):1329-1337. PubMed ID: 32112212 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients. Elmoneim HM; Samaka RM; Ali H Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854 [TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851 [TBL] [Abstract][Full Text] [Related]
9. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors]. Feng C; Li HZ; Yan WG; Luo YF; Cao JL Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147 [TBL] [Abstract][Full Text] [Related]
10. Phaeochromocytoma: a catecholamine and oxidative stress disorder. Pacak K Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192 [TBL] [Abstract][Full Text] [Related]
11. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382 [TBL] [Abstract][Full Text] [Related]
12. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy. Guo Z; Lloyd RV Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510 [TBL] [Abstract][Full Text] [Related]
13. Familial pheochromocytomas and paragangliomas: stories from the sign-out room. Perren A; Komminoth P Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482 [TBL] [Abstract][Full Text] [Related]
14. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma. Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943 [TBL] [Abstract][Full Text] [Related]
15. New insights into the genetics of familial chromaffin cell tumors. Koch CA; Vortmeyer AO; Zhuang Z; Brouwers FM; Pacak K Ann N Y Acad Sci; 2002 Sep; 970():11-28. PubMed ID: 12381538 [TBL] [Abstract][Full Text] [Related]
16. Genetics of pheochromocytomas and paragangliomas. Opocher G; Schiavi F Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163 [TBL] [Abstract][Full Text] [Related]
18. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE. Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas. Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490 [TBL] [Abstract][Full Text] [Related]
20. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]